Economic evaluation of universal newborn hepatitis B vaccination in China (Q45308262)

11 December 2017

Economic evaluation of universal newborn hepatitis B vaccination in China (English)

1 reference

11 December 2017

Sandy Qiuying Lu

1

1 reference

11 December 2017

Sarah M McGhee

2

1 reference

11 December 2017

Xu Xie

3

1 reference

11 December 2017

Jinquan Cheng

4

1 reference

11 December 2017

Richard Fielding

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

4 February 2013

1 reference

11 December 2017

1 reference

11 December 2017

31

1 reference

11 December 2017

1864-1869

1 reference

11 December 2017

14

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

11 December 2017

1 reference

Cholera vaccines: WHO position paper-Recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Long-term follow-up of hepatitis B vaccine in infants of carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

inferred from DOI database lookup

7 January 2021

based on heuristic

The influence of age on the development of the hepatitis B carrier state

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.020

10.1016/J.VACCINE.2013.01.020

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference